Saturday 17 October 2026
Export HYFT’s income statement to Excel — free account
MindWalk Holdings Corp.
HYFT Healthcare Biotechnology
MindWalk Holdings Corp.’s revenue for fiscal 2026 (year ended April 2026) was $11.3 million, down 35.9% from fiscal 2025. In the quarter to July 2026, revenue grew 19.4%, EPS fell 80.0%, free cash flow grew 9.79% and total debt fell 10.8%, each against the same quarter a year earlier.
1.31
0.09
−6.43%
Follow HYFT
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 6 | 6 | 5 |
+8 more TTM periods Free account |
| (122.85%) | (79.38%) | (63.81%) | (116.44%) | ||
| (58.55%) | (42.67%) | (37.27%) | (68.11%) | ||
ROIC |
(464.59%) | (269.05%) | (195.33%) | (164.31%) | |
Return on Tangible Assets |
(179.65%) | (96.35%) | (70.53%) | (142.81%) | |
Average Days of Receivables |
52.80 | 70.40 | 41.31 | 59.16 | |
Free Cash Flow per Share |
(0.19) | (0.20) | (0.19) | (0.16) | |
Free Cash Flow |
(9.00) | (9.32) | (8.69) | (7.31) | |
Capital Expenditures |
(0.14) | (0.29) | (0.54) | (0.59) | |
| Other line items | |||||
Cash ROIC |
(71.66%) | (49.15%) | (37.61%) | (27.13%) | |
Accounts Receivable Turnover |
7.32 | 4.31 | 6.36 | 5.23 | |
Accounts Payable Turnover |
1.46 | 1.36 | 1.91 | 1.88 | |
Inventory Turnover |
11.22 | 5.00 | 6.15 | 6.50 | |
Average Days of Payables |
309.74 | 237.91 | 167.59 | 149.83 | |
Days of Inventory on Hand |
34.78 | 28.02 | 24.63 | 23.18 | |
Tax Rate |
(0.01) | (0.03) | 0.01 | (0.08) | |
Research and Development Expense of Revenue |
31.84% | 31.71% | 24.83% | 21.65% | |
Selling, General and Administrative Expense of Revenue |
132.96% | 123.10% | 100.69% | 90.80% | |
Share Based Compensation of Revenue |
12.07% | 8.20% | 2.87% | 1.60% | |
Operating CF/Net income |
0.72 | 0.89 | 0.90 | 0.31 | |
Depreciation/Fixed assets |
0.23 | 0.40 | 0.59 | 0.81 | |
Capex/Depreciation |
(0.21) | (0.25) | (0.32) | (0.24) | |
Revenue per Share |
0.25 | 0.24 | 0.28 | 0.31 | |
Operating CF per Share |
(0.19) | (0.19) | (0.18) | (0.15) | |
Capex per Share |
0.00 | (0.01) | (0.01) | (0.01) | |
Capex to Sales |
0.01 | 0.03 | 0.04 | 0.04 |
Columns are period end dates · fundamentals updated 2 Oct 2026